abstract |
PROBLEM TO BE SOLVED: To provide a method for preventing or treating a KDM1A-mediated disease such as cancer, myeloid disease, and inflammatory disease. SOLUTION: A pharmaceutical composition containing a compound exemplified by the following compounds is applied to a KDM1A-mediated disease, preferably by oral administration. [Selection diagram] None |